News1

Nexon has launched N Connect Season 1 to support creators, connecting user participation, creator activities, and gaming experiences.

Samsung Electronics releases a free Galaxy smartphone theme inspired by the Joseon-era painting Hojakdo after user requests.

A plan is underway to connect cancer treatment at large hospitals with AI, improving local care and reducing healthcare disparities.

L&C Bio successfully raised funds through a rights offering, exceeding 100% subscription, to expand production and global operations.

Patients using Sky Labs' ring-shaped blood pressure monitor achieved better results in blood pressure control after six months.

Sears initiates a pilot program for AI-based arrhythmia detection in the UAE's national health screening initiative.

HLB Innovation's US subsidiary, Verismo Therapeutics, will present preclinical results of its KIR-CAR platform for solid tumors at an international conference.

Rigakem Bio has initiated global clinical trials for its ADC candidate LCB02A after completing the first patient dosing.

BMW Asia has opened preorders for the facelifted 7 Series luxury flagship sedan, offering four models with prices ranging from approximately $107,000 to $160,000 and extended warranty benefits for customers who register their vehicles by the end of 2026.

OpenAI has upgraded ChatGPT Voice with its GPT-Live-1.1 model, adding two Korean voices and improving conversational fluency, including while searching for information.

Kia has launched South Korea’s first pilot car-sharing service using remote-driving technology, allowing its PV5 passenger vans to travel without an onboard driver to users’ requested pickup locations.

South Korean semiconductor startup XCENA is targeting the AI inference market with technology that allows servers to share key-value caches and accelerates vector searches near memory, aiming to reduce redundant data storage and the burden of moving data across AI systems.

Wontech secures approval for laser medical device Pastelle Pro in Japan, targeting the world's fourth-largest beauty treatment market.

Celltrion showcases the competitiveness of its autoimmune treatment Remsima SC at Europe's largest gastroenterology conference.